TP53 and glioblastoma: Compared with shCont-U87 cells, increased expression of ferroptotic genes was not observed in shALOXE3-U87 cells upon Nutlin-3a and TBH treatment (Fig. 3H–I), indicating that GBM cells with ALOXE3 knockdown were resistant to p53-dependent ferroptosis.